Related Experiment Videos

Transient inhibition of murine progressive ankylosis by indomethacin

H E Krug1, M L Mahowald

  • 1Department of Medicine, Minneapolis VA Medical Center, MN 55417.

Agents and Actions
|September 1, 1991
PubMed

Insights

Indomethacin did not prevent joint ankylosis in murine progressive ankylosis (MPA) models. However, it did cause a temporary delay in thoracic joint ankylosis in these arthritis models.

Area of Science:

  • Genetics and Musculoskeletal Disorders
  • Pharmacology and Drug Efficacy

Background:

  • Murine progressive ankylosis (MPA) is a genetic disorder causing arthritis and joint fusion, resembling human ankylosing spondylitis.
  • Indomethacin is known to inhibit heterotopic bone formation.

Purpose of the Study:

  • To investigate the effects of indomethacin on the progression of joint ankylosis in a murine model of progressive ankylosis.

Main Methods:

  • Indomethacin was administered to young mice from heterozygote breeder pairs for six weeks.
  • Progression of peripheral, spinal, and thoracic joint ankylosis was compared between treated and untreated MPA animals.

Main Results:

  • Indomethacin treatment did not delay peripheral or spinal joint ankylosis in MPA mice.
  • A transient delay in thoracic joint ankylosis was observed in indomethacin-treated MPA mice.

Conclusions:

  • Indomethacin is ineffective in preventing generalized joint ankylosis in MPA.
  • Indomethacin may have a specific, albeit temporary, effect on thoracic joint fusion in this model.

Related Concept Videos